Orchestra BioMed Holdings, Inc.
OBIO
$2.60
$0.051.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.24% | -16.09% | -4.73% | 3.47% | -18.70% |
| Total Depreciation and Amortization | -2.41% | -1.19% | 10.53% | 2.70% | 0.00% |
| Total Amortization of Deferred Charges | 0.00% | 48.39% | -- | -- | -- |
| Total Other Non-Cash Items | 11.70% | -22.38% | 68.85% | -12.93% | 24.66% |
| Change in Net Operating Assets | 136.16% | 27.37% | -113.30% | -120.81% | 267.45% |
| Cash from Operations | 6.55% | -22.74% | 1.18% | -34.23% | 22.17% |
| Capital Expenditure | 69.64% | -5.66% | -55.88% | 36.45% | -1,237.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.01% | 530.57% | -587.20% | -94.07% | 79.43% |
| Cash from Investing | 25.83% | 446.36% | -773.79% | -94.66% | 77.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 78.43% | -99.66% | 8,692.40% | 850.00% |
| Repurchase of Common Stock | -10.59% | 29.64% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.59% | -102.12% | -7.24% | 8,692.40% | 850.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.25% | -17.02% | -276.74% | 386.38% | 105.38% |